Crane Company (CR) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
2 Feb, 2026Executive summary
Achieved record 2025 results with adjusted EPS up 24% year-over-year, driven by strong operational performance, margin expansion, and strategic acquisitions in advanced technologies and process flow.
Closed acquisitions of Druck, Panametrics, Reuter-Stokes, and Optek-Danulat, expanding capabilities in nuclear, process control, and instrumentation.
Announced leadership transition: Alex Alcala to become CEO in April 2026, with Max Mitchell moving to Executive Chairman.
Raised annual dividend by 11% for 2026 and declared a first quarter dividend of $0.255 per share.
Backlog growth in Aerospace & Advanced Technologies, while Process Flow Technologies saw a modest sales increase but a decline in backlog.
Financial highlights
Q4 2025 sales rose 6.8% year-over-year to $581.0M, with 5.4% core sales growth; adjusted operating profit up 15.9% to $111.7M; adjusted EPS up 21.4% to $1.53.
Full-year 2025 sales increased 8.2% to $2,305.0M; adjusted operating profit up 16.8% to $447.2M; adjusted EPS up 24% to $6.05.
Adjusted EBITDA for 2025 was $495.7M, up 16.2% year-over-year.
Adjusted free cash flow for 2025 was $362.5M, with 102% adjusted free cash conversion.
Net leverage ended 2025 at 1.1x, rising to 1.4x after acquisitions.
Outlook and guidance
2026 adjusted EPS guidance of $6.55–$6.75, representing 10% growth at midpoint, excluding non-recurring items.
2026 revenue guidance: $2,845–$2,875M, with core sales growth of 4–6% and FX tailwind of ~1%.
Acquisitions expected to be slightly accretive to 2026 earnings, with upside from synergies and deleveraging in 2027 and beyond.
Aerospace & Advanced Technologies core sales growth expected at high end of 7%-9% long-term range, with 35%-40% leverage.
Process Flow Technologies core growth expected to be flat to low single digits in 2026, with 30%-35% leverage.
Latest events from Crane Company
- Q3 2025 delivered 7.5% sales growth, 27% higher EPS, and a raised full-year outlook.CR
Q3 20253 Feb 2026 - Q2 sales up 14% and adjusted EPS up 18%, with raised full-year guidance and strong segment growth.CR
Q2 20242 Feb 2026 - Q3 2024 saw 13% sales growth, 34% higher EPS, and raised full-year guidance.CR
Q3 202418 Jan 2026 - Q4 adjusted EPS up 58%, sales up 12%, and 2025 guidance raised with a 12% dividend increase.CR
Q4 20249 Jan 2026 - Strong growth, margin expansion, and disciplined M&A set the stage for doubling business size.CR
Gabelli Funds 35th Annual Pump, Valve & Water Symposium7 Jan 2026 - Q1 2025 saw strong sales and profit growth, record backlog, and reaffirmed EPS guidance.CR
Q1 202525 Dec 2025 - Proxy details director elections, auditor ratification, and performance-based executive pay.CR
Proxy Filing1 Dec 2025 - Definitive additional proxy materials filed for shareholder voting with no fee required.CR
Proxy Filing1 Dec 2025 - Q2 sales up 9.2%, adjusted EPS up 24%, guidance raised, and major PSI acquisition announced.CR
Q2 20253 Nov 2025